Abstract.
Breast cancer cells (BCC) have calcitonin (CT) receptors, yet the action of the hormone on these cells is largely unknown. We found that CT produced a strong and transient time- and dose-dependent increase in c-fos mRNA in BCC lines. This event was prevented by a protein kinase A (PKA) inhibitor, H89. CT alone did not influence the expression of c-jun and of the tissue inhibitors of metalloproteases (timp) -1 and -2 mRNAs; however, it reduced the induction of these mRNAs by the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA), without apparent changes in the half-life of the mRNA (measured for c-jun). Along the same line, CT reduced the c-jun induction and T-47D growth stimulation by epidermal growth factor (EGF) and insulin. These effects were mimicked by forskolin and/or prevented by H89, suggesting that PKA activation was involved. These results indicate that CT modulates in BCC the mRNA levels of two important growth-related early response genes (c-fos and c-jun) and of two other genes (timp-1 and -2) involved in the control of metastatic events.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 2 May 1996 / Accepted: 10 December 1996
Rights and permissions
About this article
Cite this article
Lacroix, M., Body, J. Regulation of c-fos and c-jun Expression by Calcitonin in Human Breast Cancer Cells . Calcif Tissue Int 60, 513–519 (1997). https://doi.org/10.1007/s002239900273
Published:
Issue Date:
DOI: https://doi.org/10.1007/s002239900273